We hypothesized that the BNT162b2 mRNA vaccine was highly immunogenic; it induced inflammation, which exacerbated the patient’s APS, resulting in persistent inflammation and prolonged PF4 level elevation. This evidence concerns the gene PF4 and autoimmune polyendocrinopathy.